Quick Answer
Regen BioPharma Inc reported Research And Development Expense of $11.7 thousand for the year ending 2025.
- Regen BioPharma Inc showed a decrease of -92.4% in Research And Development Expense from 2024 to 2025.
- This data is from Regen BioPharma Inc's annual report (Form 10-K), filed with the SEC on December 30, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Regen BioPharma Inc's Research And Development Expense has grown by 39.7%.
- Historical annual values: Fiscal year 2025: $11.7 thousand | Fiscal year 2024: $153.7 thousand | Fiscal year 2023: $212.3 thousand | Fiscal year 2022: $158.1 thousand | Fiscal year 2021: $36.7 thousand | Fiscal year 2020: $13.3 thousand | Fiscal year 2019: $45.6 thousand | Fiscal year 2018: $374.4 thousand | Fiscal year 2017: $1.15 million | Fiscal year 2016: $671.1 thousand | Fiscal year 2015: $282.3 thousand | Fiscal year 2014: $23.9 thousand | Fiscal year 2013: $8.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: